These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1848297)

  • 1. Design and conformational analysis of several highly potent bradykinin receptor antagonists.
    Kyle DJ; Martin JA; Farmer SG; Burch RM
    J Med Chem; 1991 Mar; 34(3):1230-3. PubMed ID: 1848297
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides.
    Kyle DJ; Martin JA; Burch RM; Carter JP; Lu SF; Meeker S; Prosser JC; Sullivan JP; Togo J; Noronha-Blob L
    J Med Chem; 1991 Aug; 34(8):2649-53. PubMed ID: 1652027
    [No Abstract]   [Full Text] [Related]  

  • 3. New and highly potent bradykinin antagonists.
    Knolle J; Breipohl G; Henke S; Wirth K; Schölkens B
    Agents Actions Suppl; 1992; 38 ( Pt 1)():559-64. PubMed ID: 1334632
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-selectivity of new bradykinin antagonists for B1 receptors.
    Rhaleb NE; Gobeil F; Regoli D
    Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New bradykinin antagonists having very high potency at B1 receptors.
    Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
    [No Abstract]   [Full Text] [Related]  

  • 6. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.
    Farmer SG; Burch RM; Kyle DJ; Martin JA; Meeker SN; Togo J
    Br J Pharmacol; 1991 Apr; 102(4):785-7. PubMed ID: 1649657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new class of potent bradykinin antagonist dimers.
    Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
    [No Abstract]   [Full Text] [Related]  

  • 8. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor.
    Salvino JM; Seoane PR; Douty BD; Awad MM; Dolle RE; Houck WT; Faunce DM; Sawutz DG
    J Med Chem; 1993 Aug; 36(17):2583-4. PubMed ID: 8394936
    [No Abstract]   [Full Text] [Related]  

  • 10. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides.
    Kyle DJ; Martin JA; Burch RM; Carter JP; Lu S; Meeker S; Prosser JC; Sullivan JP; Togo J; Noronha-Blob L
    Agents Actions Suppl; 1992; 38 ( Pt 1)():513-25. PubMed ID: 1334629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal beta-turns.
    Kyle DJ; Blake PR; Smithwick D; Green LM; Martin JA; Sinsko JA; Summers MF
    J Med Chem; 1993 May; 36(10):1450-60. PubMed ID: 8388469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea, and are blocked by HOE 140.
    Field JL; Hall JM; Morton IK
    Br J Pharmacol; 1992 Feb; 105(2):293-6. PubMed ID: 1313723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [125I]PIP HOE 140, a high affinity radioligand for bradykinin B2 receptors.
    Brenner NJ; Stonesifer GY; Schneck KA; Burns HD; Ransom RW
    Life Sci; 1993; 53(25):1879-86. PubMed ID: 8255148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of solubilized bradykinin B2 receptors from smooth muscle and mucosa of guinea pig ileum.
    Ransom RW; Young GS; Schneck K; Goodman CB
    Biochem Pharmacol; 1992 Apr; 43(8):1823-7. PubMed ID: 1315547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
    Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
    Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of bradykinin antagonists containing indanylglycine.
    Gera L; Stewart JM
    Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea.
    Trifilieff A; Amrani Y; Landry Y; Gies JP
    Eur J Pharmacol; 1993 Aug; 239(1-3):227-9. PubMed ID: 8223898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nucleotides on [3H]bradykinin binding in guinea pig: further evidence for multiple B2 receptor subtypes.
    Seguin L; Widdowson PS
    J Neurochem; 1993 Feb; 60(2):752-7. PubMed ID: 8380442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.